TURKISH JOURNAL OF ONCOLOGY 2005 , Vol 20 , Num 1
MALIGNANT MELANOMA AND SURVIVIN
Tıb.Bio. Hilal OĞUZ1, Dr. Derya DURANYILDIZ2, Dr. Hakan ÇAMLICA3, Dr. Faruk TAŞ4, Dr. Vildan YASASEVER5, Dr. Erkan TOPUZ6
1Temel Onkoloji ABD, Kanser Biyokimyası Bilim Dalı
2Temel Onkoloji ABD
3Prevantif Onkoloji Bilim Dalı
4Klinik Onkoloji ABD
5Temel Onkoloji ABD, Kanser Biyokimyası Bilim Dalı
6Klinik Onkoloji Anabilim Dalı
Abnormalities in the control of apoptosis play an important role in tumorigenesis. We investigated the serum levels of an anti-apoptotic protein, survivin, in 44 patients with malignant melanoma using enzyme-linked immunosorbent assay (ELISA). There was no significant difference in the serum survivin level between melanoma patients and controls. In node positive patients the serum levels of survivin were unchanged after Interferon-alpha therapy but serum survivin concentrations were significantly higher in the metastatic patients than the controls. Keywords : Malignant melanoma, survivin, serum